Herbert C. Chen

Herbert C. Chen's AcademicInfluence.com Rankings

Herbert C. Chen

Medical

#2566

World Rank

#2995

Historical Rank

Surgery

#209

World Rank

#258

Historical Rank

medical Degrees

Download Badge

Medical

Why Is Herbert C. Chen Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Herbert C. Chen's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Consensus guidelines for the management and treatment of neuroendocrine tumors. (2013) (486)
The North American Neuroendocrine Tumor Society Consensus Guideline for the Diagnosis and Management of Neuroendocrine Tumors: Pheochromocytoma, Paraganglioma, and Medullary Thyroid Cancer (2010) (474)
Higher serum thyroid stimulating hormone level in thyroid nodule patients is associated with greater risks of differentiated thyroid cancer and advanced tumor stage. (2008) (459)
Murray and Nadel’s Textbook of Respiratory Medicine (2012) (435)
An achaete-scute homologue essential for neuroendocrine differentiation in the lung (1997) (394)
Should All Papillary Thyroid Microcarcinomas Be Aggressively Treated?: An Analysis of 18,445 Cases (2011) (251)
Is Hashimoto's thyroiditis a risk factor for papillary thyroid cancer? (2008) (215)
Intraoperative parathyroid hormone testing improves cure rates in patients undergoing minimally invasive parathyroidectomy. (2005) (214)
A Comprehensive Evaluation of Perioperative Adjuncts During Minimally Invasive Parathyroidectomy: Which Is Most Reliable? (2005) (210)
Why do students choose careers in surgery? (2003) (188)
Pheochromocytoma: current approaches and future directions. (2008) (179)
Secondary and tertiary hyperparathyroidism, state of the art surgical management. (2009) (176)
Current management of medullary thyroid cancer. (2008) (175)
Tumor suppressor role of Notch-1 signaling in neuroendocrine tumors. (2007) (172)
Subclinical Cushing's syndrome in adrenal incidentalomas. (2004) (161)
Metastatic neuroendocrine hepatic tumors: resection improves survival. (2006) (150)
Incidence and Localization of Ectopic Parathyroid Adenomas in Previously Unexplored Patients (2012) (150)
Follicular Lesions of the Thyroid: Does Frozen Section Evaluation After Operative Management? (1995) (149)
Accuracy of fine-needle aspiration biopsy for predicting neoplasm or carcinoma in thyroid nodules 4 cm or larger. (2009) (148)
Radioguided Parathyroidectomy Is Equally Effective for Both Adenomatous and Hyperplastic Glands (2003) (148)
Valproic acid activates notch-1 signaling and regulates the neuroendocrine phenotype in carcinoid cancer cells. (2007) (137)
The role of Cdk5 in neuroendocrine thyroid cancer. (2013) (135)
Overexpression of the NOTCH1 Intracellular Domain Inhibits Cell Proliferation and Alters the Neuroendocrine Phenotype of Medullary Thyroid Cancer Cells* (2006) (130)
Hypoparathyroidism after total thyroidectomy: incidence and resolution. (2015) (125)
Follicular variant of papillary thyroid carcinoma is a unique clinical entity: a population-based study of 10,740 cases. (2013) (124)
Higher serum TSH in thyroid cancer patients occurs independent of age and correlates with extrathyroidal extension (2009) (121)
Inactivation of glycogen synthase kinase-3β, a downstream target of the raf-1 pathway, is associated with growth suppression in medullary thyroid cancer cells (2007) (113)
Regulation of neuroendocrine differentiation in gastrointestinal carcinoid tumor cells by notch signaling. (2005) (113)
Effective surgical residents strongly influence medical students to pursue surgical careers. (2005) (111)
Thyroid hormone replacement after thyroid lobectomy. (2009) (108)
In patients with thyroid cancer of follicular cell origin, a family history of nonmedullary thyroid cancer in one first-degree relative is associated with more aggressive disease. (2012) (100)
Co-delivery of doxorubicin and siRNA using octreotide-conjugated gold nanorods for targeted neuroendocrine cancer therapy. (2012) (99)
Operative Failures After Parathyroidectomy for Hyperparathyroidism: The Influence of Surgical Volume (2010) (91)
Current understanding and management of medullary thyroid cancer. (2013) (91)
Pancreatic endocrine tumors. (2004) (91)
Conservation of the Notch1 signaling pathway in gastrointestinal carcinoid cells. (2005) (89)
Parathyroid hormone deficiency after total thyroidectomy: incidence and time. (2010) (88)
Raf-1 activation suppresses neuroendocrine marker and hormone levels in human gastrointestinal carcinoid cells. (2003) (88)
Is minimally invasive parathyroidectomy associated with greater recurrence compared to bilateral exploration? Analysis of more than 1,000 cases. (2012) (86)
The HDAC inhibitor trichostatin A inhibits growth of small cell lung cancer cells. (2007) (86)
The Utility of Intraoperative Bilateral Internal Jugular Venous Sampling With Rapid Parathyroid Hormone Testing (2007) (85)
Gastrointestinal Carcinoid Tumors: Factors that Predict Outcome (2004) (85)
A multi-institutional international study of risk factors for hematoma after thyroidectomy. (2013) (83)
Resveratrol Induces Differentiation Markers Expression in Anaplastic Thyroid Carcinoma via Activation of Notch1 Signaling and Suppresses Cell Growth (2013) (83)
Chrysin activates Notch1 signaling and suppresses tumor growth of anaplastic thyroid carcinoma in vitro and in vivo (2013) (82)
Primary thyroid lymphoma: Can the diagnosis be made solely by fine-needle aspiration? (2002) (82)
Medical student operative experience correlates with a match to a categorical surgical program. (2003) (81)
Predictors of Recurrence in Primary Hyperparathyroidism: An Analysis of 1386 Cases (2014) (80)
MicroRNA profiling of benign and malignant pheochromocytomas identifies novel diagnostic and therapeutic targets. (2010) (80)
RISKS AND CONSEQUENCES OF INCIDENTAL PARATHYROIDECTOMY DURING THYROID RESECTION (2007) (78)
Contralateral papillary thyroid cancer: does size matter? (2009) (78)
Lymph node ratio predicts recurrence in papillary thyroid cancer. (2012) (78)
ZM336372, a Raf-1 activator, suppresses growth and neuroendocrine hormone levels in carcinoid tumor cells (2005) (76)
Motivation to pursue surgical subspecialty training: is there a gender difference? (2007) (75)
Surgery for primary hyperparathyroidism: what is the best approach? (2002) (74)
A pilot phase II study of valproic acid for treatment of low-grade neuroendocrine carcinoma. (2011) (74)
Controversies in the surgical management of newly diagnosed and recurrent/residual thyroid cancer. (2009) (74)
Apoptosis-mediated medullary thyroid cancer growth suppression by the PI3K inhibitor LY294002. (2006) (72)
Valproic Acid Activates Notch1 Signaling and Induces Apoptosis in Medullary Thyroid Cancer Cells (2008) (71)
Long-Term Follow-Up of Patients With Tertiary Hyperparathyroidism Treated by Resection of a Single or Double Adenoma (2002) (70)
Total thyroidectomy: a safe and effective treatment for Graves' disease. (2009) (70)
The role of human achaete-scute homolog-1 in medullary thyroid cancer cells. (2003) (69)
Down-regulation of Notch1 signaling inhibits tumor growth in human hepatocellular carcinoma. (2009) (68)
Outcomes of surgically managed pediatric thyroid cancer. (2009) (68)
Role of postoperative vitamin D and/or calcium routine supplementation in preventing hypocalcemia after thyroidectomy: a systematic review and meta-analysis. (2013) (67)
The utility of frozen section evaluation for follicular thyroid lesions (2006) (65)
Mitogen-activated protein kinases and chemoresistance in pancreatic cancer cells. (2006) (64)
Carcinoid tumors. (2008) (62)
Radioguided parathyroidectomy in patients with secondary and tertiary hyperparathyroidism. (2003) (62)
Presurgical Localization of Parathyroid Adenomas with Magnetic Resonance Imaging at 3.0 T: An Adjunct Method to Supplement Traditional Imaging (2012) (61)
Same-day thyroidectomy program: eligibility and safety evaluation. (2012) (60)
Postoperative parathyroid hormone testing decreases symptomatic hypocalcemia and associated emergency room visits after total thyroidectomy. (2010) (60)
Thyroid Resection Improves Perception of Swallowing Function in Patients with Thyroid Disease (2009) (58)
Equal oncologic results for laparoscopic and open resection of adrenal metastases. (2007) (57)
A Comparison of the LigaSure and Harmonic Scalpel in Thyroid Surgery: A Single Institution Review (2010) (57)
Valproic acid induces Notch1 signaling in small cell lung cancer cells. (2008) (57)
Parathyroidectomy for primary hyperparathyroidism in octogenarians and nonagenarians: a risk-benefit analysis. (2007) (57)
The surgical management of Graves' disease. (2006) (57)
Hairy Enhancer of Split-1 (HES-1), a Notch1 effector, inhibits the growth of carcinoid tumor cells. (2005) (56)
Creation of a “Wisconsin Index” Nomogram to Predict the Likelihood of Additional Hyperfunctioning Parathyroid Glands During Parathyroidectomy (2013) (56)
Are there predictors of malignancy in patients with multinodular goiter? (2011) (55)
Suberoyl bis-hydroxamic acid activates Notch-1 signaling and induces apoptosis in medullary thyroid carcinoma cells. (2008) (55)
Cancer after thyroidectomy: a multi-institutional experience with 1,523 patients. (2013) (55)
Is central lymph node dissection necessary for parathyroid carcinoma? (2014) (54)
Hesperetin Activates the Notch1 Signaling Cascade, Causes Apoptosis, and Induces Cellular Differentiation in Anaplastic Thyroid Cancer (2014) (54)
Hesperetin, a potential therapy for carcinoid cancer. (2011) (53)
Is thyroidectomy in patients with Hashimoto thyroiditis more risky? (2012) (53)
Optimizing Outpatient Pain Management After Thyroid and Parathyroid Surgery: A Two-Institution Experience (2017) (52)
Fine-Needle Aspiration Optimizes Surgical Management in Patients With Thyroid Cancer (2006) (52)
Surgery improves quality of life in patients with "mild" hyperparathyroidism. (2009) (51)
Novel approaches in anaplastic thyroid cancer therapy. (2014) (51)
Antiproliferative effect of chrysin on anaplastic thyroid cancer. (2011) (51)
The Raf-1 pathway: a molecular target for treatment of select neuroendocrine tumors? (2006) (51)
Using body mass index to predict optimal thyroid dosing after thyroidectomy. (2013) (51)
Impact of Lymph Node Ratio on Survival in Papillary Thyroid Cancer (2013) (51)
Identification and validation of Notch pathway activating compounds through a novel high‐throughput screening method (2011) (51)
Treatment of advanced carcinoid tumors (2006) (51)
Palliative thyroidectomy for malignant lymphoma of the thyroid (2002) (50)
Medullary thyroid cancer: the functions of raf-1 and human achaete-scute homologue-1. (2005) (49)
What is the Clinical Significance of an Elevated Parathyroid Hormone Level After Curative Surgery for Primary Hyperparathyroidism? (2009) (49)
Evaluation and management of the pediatric thyroid nodule. (2015) (49)
Long-Term Outcomes in Patients With Calciphylaxis From Hyperparathyroidism (2006) (48)
Resveratrol Induces Notch2-Mediated Apoptosis and Suppression of Neuroendocrine Markers in Medullary Thyroid Cancer (2011) (48)
Papillary Thyroid Microcarcinomas: Big Decisions for a Small Tumor (2009) (48)
The effectiveness of radioguided parathyroidectomy in patients with negative technetium tc 99m-sestamibi scans. (2009) (47)
Radioguided Parathyroidectomy via VATS Combined With Intraoperative Parathyroid Hormone Testing: The Surgical Approach of Choice for Patients With Mediastinal Parathyroid Adenomas? (2002) (47)
Symptomatic benign multinodular goiter: unilateral or bilateral thyroidectomy? (2007) (46)
The role of intraoperative frozen section if suspicious for papillary thyroid cancer. (2008) (46)
The Role of Gender in Primary Hyperparathyroidism: Same Disease, Different Presentation (2012) (45)
New trends in parathyroid surgery. (2010) (45)
Remnant uptake as a postoperative oncologic quality indicator. (2013) (45)
Training our future endocrine surgeons: a look at the endocrine surgery operative experience of U.S. surgical residents. (2010) (44)
Preventing Postoperative Hypocalcemia in Patients with Graves Disease: A Prospective Study (2014) (44)
Safety and feasibility of laparoscopic resection for large (≥ 6 CM) pheochromocytomas without suspected malignancy. (2012) (43)
How long should we follow patients after apparently curative parathyroidectomy? (2017) (42)
Histone deacetylase inhibitors upregulate Notch-1 and inhibit growth in pheochromocytoma cells. (2008) (42)
Is Tumor Size the Best Predictor of Outcome for Papillary Thyroid Cancer? (2006) (42)
What is the biology and optimal treatment for papillary microcarcinoma of the thyroid? (2006) (42)
Older Age and Larger Tumor Size Predict Malignancy in Hürthle Cell Neoplasms of the Thyroid (2008) (41)
Secondary and Tertiary Hyperparathyroidism: The Utility of ioPTH Monitoring (2010) (41)
Preserving function and quality of life after thyroid and parathyroid surgery. (2008) (40)
Notch1 mediates growth suppression of papillary and follicular thyroid cancer cells by histone deacetylase inhibitors (2009) (40)
The role of intraoperative parathyroid hormone testing in patients with tertiary hyperparathyroidism after renal transplantation. (2005) (40)
Surgical site infection after thyroidectomy: a rare but significant complication. (2014) (40)
Computed Tomography in the Diagnosis of Acute Appendicitis: Definitive or Detrimental? (2007) (40)
Tertiary hyperparathyroidism: is less than a subtotal resection ever appropriate? A study of long-term outcomes. (2009) (40)
A Rising IoPTH Level Immediately After Parathyroid Resection: Are Additional Hyperfunctioning Glands Always Present? An Application of the Wisconsin Criteria (2010) (40)
The incidence of thyroid cancer by fine needle aspiration varies by age and gender. (2013) (40)
Radioguided thoracoscopic mediastinal parathyroidectomy with intraoperative parathyroid hormone testing. (2005) (40)
Octreotide-functionalized and resveratrol-loaded unimolecular micelles for targeted neuroendocrine cancer therapy. (2013) (39)
Recurrent and persistence primary hyperparathyroidism occurs more frequently in patients with double adenomas. (2014) (39)
Intrathyroidal parathyroid glands: small, but mighty (a Napoleon phenomenon). (2012) (39)
Postoperative surveillance of small appendiceal carcinoid tumors. (2014) (39)
Toxic Nodular Goiter and Cancer: A Compelling Case for Thyroidectomy (2013) (39)
The Negative Sestamibi Scan: Is a Minimally Invasive Parathyroidectomy Still Possible? (2007) (38)
Consequences of parathyroidectomy in patients with "mild" sporadic primary hyperparathyroidism. (2007) (38)
Influence of surgical volume on operative failures for hyperparathyroidism. (2011) (38)
What is the utility of distal forearm DXA in primary hyperparathyroidism? (2012) (38)
Tumor-Suppressor Role of Notch3 in Medullary Thyroid Carcinoma Revealed by Genetic and Pharmacological Induction (2014) (37)
Failure of Radioactive Iodine in the Treatment of Hyperthyroidism (2014) (37)
The Influence of Surgical Approach on Quality of Life After Parathyroid Surgery (2008) (37)
Combination Therapy with Histone Deacetylase Inhibitors and Lithium Chloride: A Novel Treatment for Carcinoid Tumors (2009) (36)
An intact parathyroid hormone-based protocol for the prevention and treatment of symptomatic hypocalcemia after thyroidectomy. (2014) (36)
Novel Thyroidectomy Difficulty Scale Correlates with Operative Times (2014) (36)
The Utility of Metaiodobenzylguanidine (MIBG) Scintigraphy in Patients with Pheochromocytoma (2008) (35)
Nondiagnostic fine-needle aspirations of the thyroid: is the risk of malignancy higher? (2013) (35)
Inhibition of Phosphatidylinositol 3-Kinase/Akt Signaling Suppresses Tumor Cell Proliferation and Neuroendocrine Marker Expression in GI Carcinoid Tumors (2009) (35)
Identifying predictors of a difficult thyroidectomy. (2014) (35)
Specific glycogen synthase kinase-3 inhibition reduces neuroendocrine markers and suppresses neuroblastoma cell growth (2014) (35)
What is the optimal treatment for children with primary hyperparathyroidism? (2010) (34)
Inhibition of growth in medullary thyroid cancer cells with histone deacetylase inhibitors and lithium chloride. (2009) (34)
Utility of Intraoperative PTH for Primary Hyperparathyroidism Due to Multigland Disease (2009) (34)
Parathyroidectomy is underused in patients with tertiary hyperparathyroidism after renal transplantation. (2016) (34)
Antiplatelet and Anticoagulant Medications Significantly Increase the Risk of Postoperative Hematoma: Review of over 4500 Thyroid and Parathyroid Procedures (2016) (34)
Multigland Disease and Slower Decline in Intraoperative PTH Characterize Mild Primary Hyperparathyroidism (2013) (34)
Advances in surgical therapy for thyroid cancer (2011) (34)
A mouse model of carcinoid syndrome and heart disease. (2004) (33)
Azacytidine induces cell cycle arrest and suppression of neuroendocrine markers in carcinoids. (2010) (33)
Limitations of the ACS NSQIP in Thyroid Surgery (2011) (33)
Clinical and Socioeconomic Factors Influence Treatment Decisions in Graves’ Disease (2015) (33)
Parathyroid Cryopreservation after Parathyroidectomy: A Worthwhile Practice? (2013) (33)
Should patients with symptomatic Hashimoto's thyroiditis pursue surgery? (2011) (33)
A prospective evaluation of novel methods to intraoperatively distinguish parathyroid tissue utilizing a parathyroid hormone assay. (2006) (33)
Insulin-like growth factor 1 signaling in human gastrointestinal carcinoid tumor cells. (2004) (33)
All Thyroid Ultrasound Evaluations are Not Equal: Sonographers Specialized in Thyroid Cancer Correctly Label Clinical N0 Disease in Well Differentiated Thyroid Cancer (2014) (33)
Does routine use of ultrasound result in additional thyroid procedures in patients with primary hyperparathyroidism? (2009) (33)
Justified Follow-Up: A Final Intraoperative Parathyroid Hormone (ioPTH) Over 40 pg/mL is Associated with an Increased Risk of Persistence and Recurrence in Primary Hyperparathyroidism (2015) (33)
Unilateral thyroidectomy for the treatment of benign multinodular goiter. (2013) (32)
Do the best students go into general surgery? (2003) (32)
Radioguided parathyroidectomy for hyperparathyroidism in the reoperative neck. (2009) (32)
Changing trends for surgery in elderly patients with hyperparathyroidism at a single institution. (2005) (32)
Does propofol anesthesia affect intraoperative parathyroid hormone levels? A randomized, prospective trial. (2004) (32)
Suberoyl Bishydroxamic Acid Activates Notch1 Signaling and Suppresses Tumor Progression in an Animal Model of Medullary Thyroid Carcinoma (2008) (32)
Can biochemical abnormalities predict symptomatology in patients with primary hyperparathyroidism? (2011) (31)
Thyroidectomy for Graves' disease in children: Indications and complications. (2016) (31)
Is DVT prophylaxis necessary for thyroidectomy and parathyroidectomy? (2010) (31)
Diagnostic Utility of Fine-Needle Aspiration Cytology in Pediatric Differentiated Thyroid Cancer (2010) (30)
Lithium ions: a novel treatment for pheochromocytomas and paragangliomas. (2007) (30)
Infrared thermographic profiles of vessel sealing devices on thyroid parenchyma. (2011) (30)
Multi-targeted approach in the treatment of thyroid cancer (2008) (30)
Tautomycetin and tautomycin suppress the growth of medullary thyroid cancer cells via inhibition of glycogen synthase kinase-3β (2009) (30)
Radioactive Iodine Remnant Uptake After Completion Thyroidectomy: Not Such a Complete Cancer Operation (2014) (30)
Evolution of pediatric thyroid surgery at a tertiary medical center. (2011) (30)
The phosphatidylinositol 3-kinase/akt signaling pathway in medullary thyroid cancer. (2008) (29)
Lithium inhibits carcinoid cell growth in vitro. (2010) (29)
The use of the Ligasure for hemostasis during thyroid lobectomy. (2008) (29)
No need to abandon unilateral parathyroid surgery. (2012) (29)
Radioguided Parathyroid surgery. (2004) (29)
Suberoyl Bishydroxamic Acid Inhibits Cellular Proliferation by Inducing Cell Cycle Arrest in Carcinoid Cancer Cells (2007) (29)
Activation of the ras/raf-1 signal transduction pathway in carcinoid tumor cells results in morphologic transdifferentiation. (2002) (29)
Phosphatidylinositol 3-kinase-Akt signaling in pulmonary carcinoid cells. (2009) (29)
Identification of a Novel Raf-1 Pathway Activator that Inhibits Gastrointestinal Carcinoid Cell Growth (2010) (29)
Initial lymph node dissection increases cure rates in patients with medullary thyroid cancer. (2007) (28)
In-vivo activation of Raf-1 inhibits tumor growth and development in a xenograft model of human medullary thyroid cancer (2006) (27)
Are surgical progeny more likely to pursue a surgical career? (2008) (26)
Substernal goiter: when is a sternotomy required? (2015) (26)
The novel histone deacetylase inhibitor thailandepsin A inhibits anaplastic thyroid cancer growth. (2014) (26)
Xanthohumol inhibits the neuroendocrine transcription factor achaete-scute complex-like 1, suppresses proliferation, and induces phosphorylated ERK1/2 in medullary thyroid cancer. (2010) (25)
Thiocoraline activates the Notch pathway in carcinoids and reduces tumor progression in vivo (2014) (25)
Is intraoperative parathyroid hormone monitoring necessary with ipsilateral parathyroid gland visualization during anticipated unilateral exploration for primary hyperparathyroidism: a two-institution analysis of more than 2,000 patients. (2014) (25)
A Survey of Preferences Regarding Surgical Approach to Thyroid Surgery (2014) (25)
AKT and PTEN expression in human gastrointestinal carcinoid tumors. (2009) (25)
Radioguided Parathyroidectomy in Patients with Familial Hyperparathyroidism (2007) (25)
Hereditary Medullary Thyroid Cancer: Age-Appropriate Thyroidectomy Improves Disease-Free Survival (2012) (25)
Notch in the development of thyroid C-cells and the treatment of medullary thyroid cancer. (2010) (25)
Local/Cervical Block Anesthesia versus General Anesthesia for Minimally Invasive Parathyroidectomy: What are the Advantages? (2007) (24)
Increased efficiency of endocrine procedures performed in an ambulatory operating room. (2013) (24)
ZM336372, a Raf-1 activator, inhibits growth of pheochromocytoma cells. (2006) (24)
Isolated Adrenal Mass in Patients with a History of Cancer: Remember Pheochromocytoma (2007) (23)
Radioguided Parathyroidectomy for Recurrent Parathyroid Cancer (2007) (23)
Current treatment of papillary thyroid microcarcinoma. (2012) (23)
Timing of symptom improvement after parathyroidectomy for primary hyperparathyroidism. (2013) (23)
Radioguided parathyroidectomy effective in pediatric patients. (2013) (23)
Persistent hypertension after adrenalectomy for an aldosterone-producing adenoma: weight as a critical prognostic factor for aldosterone's lasting effect on the cardiac and vascular systems. (2012) (23)
Expression of the active Notch1 decreases MTC tumor growth in vivo. (2011) (22)
Leflunomide suppresses growth in human medullary thyroid cancer cells. (2013) (22)
Signaling Pathways as Specific Pharmacologic Targets for Neuroendocrine Tumor Therapy: RET, PI3K, MEK, Growth Factors, and Notch (2012) (22)
Hypothyroidism after a cancer diagnosis: etiology, diagnosis, complications, and management. (2014) (22)
Parathyroid conditions in childhood. (2014) (22)
A preclinical and clinical study of lithium in low-grade neuroendocrine tumors. (2011) (22)
Is intraoperative parathyroid hormone testing in patients with renal insufficiency undergoing parathyroidectomy for primary hyperparathyroidism accurate? (2015) (21)
Improvement of Sleep Disturbance and Insomnia Following Parathyroidectomy for Primary Hyperparathyroidism (2014) (21)
Higher Serum TSH Level in Thyroid Nodule Patients is Associated with Greater Risks of Differentiated Thyroid Cancer and Advanced Tumor Stage (2007) (21)
Prospective Intervention of a Novel Levothyroxine Dosing Protocol Based on Body Mass Index after Thyroidectomy. (2014) (21)
Lymph Node Metastases do not Impact Survival in Follicular Variant Papillary Thyroid Cancer (2014) (21)
Clinicopathologic characteristics of colonic carcinoid tumors. (2013) (21)
Neuroendocrine phenotype alteration and growth suppression through apoptosis by MK-2206, an allosteric inhibitor of AKT, in carcinoid cell lines in vitro (2013) (20)
Chronic Abdominal Pain and Upper Gastrointestinal Bleeding Due to Duodenal Perforation Caused by Migrated Inferior Vena Cava Filter (2004) (20)
Sodium butyrate activates Notch1 signaling, reduces tumor markers, and induces cell cycle arrest and apoptosis in pheochromocytoma. (2009) (20)
Radioguided Parathyroidectomy for Recurrent Hyperparathyroidism Caused by Forearm Graft Hyperplasia (2003) (20)
Markedly elevated thyroglobulin levels in the preoperative thyroidectomy patient correlates with metastatic burden. (2014) (20)
Incidence of concomitant hyperparathyroidism in patients with thyroid disease requiring surgery. (2012) (20)
Neuroendocrine tumor cell growth inhibition by ZM336372 through alterations in multiple signaling pathways. (2007) (20)
25-Hydroxyvitamin D Status Does Not Affect Intraoperative Parathyroid Hormone Dynamics in Patients with Primary Hyperparathyroidism (2010) (20)
Adenomas of cervical maldescended parathyroid glands: pearls and pitfalls (2015) (19)
Kidney Disease Improving Global Outcomes guidelines and parathyroidectomy for renal hyperparathyroidism. (2015) (19)
Medullary Thyroid Carcinoma: Targeted Therapies and Future Directions (2009) (19)
Palliation of advanced thyroid malignancies. (2007) (18)
Carcinoid tumors. (2006) (18)
Fine needle aspiration of the thyroid: a contemporary experience of 3981 cases. (2011) (18)
Early-phase technetium-99m sestamibi scintigraphy can improve preoperative localization in primary hyperparathyroidism. (2013) (17)
Disease outcomes and nodal recurrence in patients with papillary thyroid cancer and lateral neck nodal metastases (2014) (17)
AB3-Loaded and Tumor-Targeted Unimolecular Micelles for Medullary Thyroid Cancer Treatment. (2017) (17)
Sestamibi Imaging for Primary Hyperparathyroidism: The Impact of Surgeon Interpretation and Radiologist Volume (2012) (17)
Distinguishing classical papillary thyroid microcancers from follicular-variant microcancers. (2014) (16)
The Need for Intraoperative Parathyroid Hormone Monitoring During Radioguided Parathyroidectomy by Video-Assisted Thoracoscopy (VATS) (2006) (16)
Illustrative handbook of general surgery (2010) (16)
Novel targets for the treatment and palliation of gastrointestinal neuroendocrine tumors. (2008) (16)
Thiocoraline alters neuroendocrine phenotype and activates the Notch pathway in MTC-TT cell line (2013) (16)
The Necessity and Reliability of Intraoperative Parathyroid Hormone (PTH) Testing in Patients with Mild Hyperparathyroidism and PTH Levels in the Normal Range (2011) (16)
Symptoms of gastroesophageal reflux disease improve after parathyroidectomy. (2012) (16)
Incisions and Exposure of the Neck for Thyroidectomy and Parathyroidectomy (2008) (16)
Does the Final Intraoperative PTH Level Really Have to Fall into the Normal Range to Signify Cure? (2012) (16)
False-negative fine-needle aspiration of thyroid nodules cannot be attributed to sampling error alone. (2012) (16)
Synchronous and antecedent nonthyroidal malignancies in patients with papillary thyroid carcinoma. (2013) (15)
Breast Radiation Correlates with Side of Parathyroid Adenoma (2012) (15)
Preoperative ultrasonography findings predict the need for repeated surgery in papillary thyroid cancer. (2012) (15)
Is previous same quadrant surgery a contraindication to laparoscopic adrenalectomy? (2012) (15)
Signaling mechanisms in neuroendocrine tumors as targets for therapy. (2010) (15)
CaPTHUS Scoring Model in Primary Hyperparathyroidism: Can It Eliminate the Need for ioPTH Testing? (2015) (15)
Clinical efficacy of fine-needle aspiration biopsy of thyroid nodules in males. (2010) (15)
Endoscopic transanal resection provides palliation equivalent to transabdominal resection in patients with metastatic rectal cancer (2001) (15)
Does frozen section alter surgical management of multinodular thyroid disease? (2006) (14)
Neurocognitive dysfunction: a predictor of parathyroid hyperplasia. (2009) (14)
Radioguided techniques for parathyroid surgery. (2005) (14)
Does academic advancement impact teaching performance of surgical faculty? (2004) (14)
Can Thallium-Pertechnetate Subtraction Scanning Play a Role in the Preoperative Imaging for Minimally Invasive Parathyroidectomy? (2004) (14)
Revisiting adrenal mass size as an indication for adrenalectomy. (2009) (14)
Primary hyperparathyroidism across the ages: presentation and outcomes. (2014) (14)
Role of cervical ultrasound in detecting thyroid pathology in primary hyperparathyroidism. (2014) (14)
The changing pattern of diagnosing primary hyperparathyroidism in young patients. (2017) (14)
Influence of morbid obesity on parathyroidectomy outcomes in primary hyperparathyroidism. (2010) (14)
Primary hyperparathyroidism. (2016) (13)
Utilization of Fine-needle Aspiration in Patients Undergoing Thyroidectomy at Two Academic Centers across the Atlantic (2003) (13)
Intraoperative Parathyroid Hormone Levels at 5 min Can Identify Multigland Disease (2017) (13)
MG-132 inhibits carcinoid growth and alters the neuroendocrine phenotype. (2010) (13)
How should medical student surgical rotations be structured to optimize education? (2004) (13)
Ex vivo radioactive counts and decay rates of tissues resected during radioguided parathyroidectomy. (2006) (13)
Thyroidectomy decreases snoring and sleep apnea symptoms. (2012) (13)
ACTH-producing carcinoma of the pituitary with refractory Cushing's Disease and hepatic metastases: a case report and review of the literature (2009) (13)
Synergistic Effect of Pasireotide and Teriflunomide in Carcinoids in vitro (2012) (13)
Outcomes After Subtotal Parathyroidectomy for Primary Hyperparathyroidism due to Hyperplasia: Significance of Whole vs. Partial Gland Remnant (2015) (13)
Radioguided parathyroidectomy for tertiary hyperparathyroidism. (2015) (12)
What is the Added Benefit of Cervical Ultrasound to 99mTc-Sestamibi Scanning in Primary Hyperparathyroidism? (2011) (12)
A short-stay unit for thyroidectomy patients increases discharge efficiency. (2013) (12)
Tautomycin suppresses growth and neuroendocrine hormone markers in carcinoid cells through activation of the Raf-1 pathway. (2009) (12)
Single Gland, Ectopic Location: Adenomas are Common Causes of Primary Hyperparathyroidism in Children and Adolescents (2020) (12)
Thallium-Pertechnetate Subtraction Scanning in the Preoperative Localization of an Ectopic Undescended Parathyroid Gland (2004) (12)
Regulation of cell-cell contact molecules and the metastatic phenotype of medullary thyroid carcinoma by the Raf-1/MEK/ERK pathway. (2008) (12)
Focal Adhesion Kinase, a Downstream Mediator of Raf-1 Signaling, Suppresses Cellular Adhesion, Migration, and Neuroendocrine Markers in BON Carcinoid Cells (2010) (12)
Three large, functioning cystic parathyroid adenomas. (2012) (11)
The effect of cinacalcet on intraoperative findings in tertiary hyperparathyroidism patients undergoing parathyroidectomy. (2014) (11)
Surveillance of Small Rectal Carcinoid Tumors in the Absence of Metastatic Disease (2012) (11)
Surgeon and Staff Radiation Exposure During Radioguided Parathyroidectomy at a High-Volume Institution (2014) (10)
An Update on Carcinoid Tumors (2003) (10)
Encapsulated follicular variant of papillary thyroid cancer: are these tumors really benign? (2017) (10)
Radioguided Reoperative Parathyroidectomy for Persistent Primary Hyperparathyroidism (2008) (10)
Elevated parathyroid hormone after parathyroidectomy delays symptom improvement. (2014) (10)
ZM336372, A Raf-1 Activator, Causes Suppression of Proliferation in a Human Hepatocellular Carcinoma Cell Line (2008) (10)
Raf-1 activation in gastrointestinal carcinoid cells decreases tumor cell adhesion. (2007) (9)
MK-2206 Causes Growth Suppression and Reduces Neuroendocrine Tumor Marker Production in Medullary Thyroid Cancer Through Akt Inhibition (2013) (9)
Does Previous Head and Neck Irradiation Increase the Chance of Multigland Disease in Patients with Hyperparathyroidism? (2011) (9)
Intraoperative adjuncts for parathyroid surgery (2011) (9)
Validation of the “Perrier” Parathyroid Adenoma Location Nomenclature (2012) (9)
When patients call their surgeon's office: an opportunity to improve the quality of surgical care and prevent readmissions. (2016) (8)
The Incidence of Thyroid Cancer by FNA Varies by Age and Gender (2012) (8)
Significance of rebounding parathyroid hormone levels during parathyroidectomy. (2013) (8)
Primary hyperparathyroidism. (2010) (7)
Role of menin in neuroendocrine tumorigenesis. (2009) (7)
ZM336372 induces apoptosis associated with phosphorylation of GSK-3beta in pancreatic adenocarcinoma cell lines. (2010) (7)
Thyroidectomy as Primary Treatment Optimizes Body Mass Index in Patients with Hyperthyroidism (2014) (7)
Notch 1 mediates growth suppression of papillary and follicular thyroid cancer cells by histone deacetylase inhibitors (2009) (7)
Follicular thyroid cancer cell growth inhibition by proteosome inhibitor MG132. (2009) (7)
Incidental carcinoid tumors of the appendix: do they affect presentation or prognosis? (2007) (7)
Thyroglobulin antibody resolution after total thyroidectomy for cancer. (2015) (7)
Advances in surgical therapy for thyroid cancer (2012) (7)
Therapeutic options for patients with metastatic gastrointestinal carcinoid (2008) (7)
Notch3 as a novel therapeutic target in metastatic medullary thyroid cancer (2018) (6)
QS264. Factors That Predict Malignancy in HÜrthle Cell Neoplasms of the Thyroid (2008) (6)
Radioactive iodine scanning is not beneficial but its use persists for euthyroid patients. (2013) (6)
Changes in swallowing-related quality of life after parathyroidectomy for hyperparathyroidism: a prospective cohort study. (2012) (6)
Resveratrol-Induced Notch Activation Potentially Mediates Autophagy in Human Follicular Thyroid Cancer Cells (2010) (6)
Presentation, Management, and Outcomes of Hyperparathyroidism in Octogenarians and Nonagenarians (2013) (6)
Inhibition of the PI3K Pathway Suppresses Hormonal Secretion and Limits Growth in Pheochromocytoma Cells (2009) (6)
Routine Chest X-Ray Prior to Thyroid Surgery: Is It Always Necessary? (2012) (6)
Panobinostat, a novel histone deacetylase inhibitor, in advanced medullary and iodine-refractory differentiated thyroid cancer: A Wisconsin Oncology Network trial. (2013) (5)
Utility of 111Indium-pentetreotide Scintigraphy in Patients with Neuroendocrine Tumors (2013) (5)
Tumor Suppressor Role of Notch1 and Raf-1 Signaling in Medullary Thyroid Cancer Cells (2007) (5)
A phase II study of the histone deacetylase inhibitor panobinostat (LBH589) in low-grade neuroendocrine tumors. (2012) (5)
Do additional imaging studies change operative management in patients undergoing adrenalectomy? (2015) (5)
Reoperative Endocrine Surgery (2008) (5)
Hürthle cell metaplasia on fine-needle aspiration biopsy is not by itself an indication for thyroid surgery. (2012) (5)
Multifunctional Gold Nanorods for Targeted Drug Delivery To Carcinoids (2012) (4)
Association for Academic Surgery presidential address Episode VI: The return of the surgeon. (2009) (4)
Routine Chest X-ray Prior to Thyroid Surgery? Is it Always Necessary? (2012) (4)
Inadequate Cytology of Thyroid Nodules. Repeat It or Live With It (2011) (4)
99. Valproic Acid Activates the Notch1 Signaling Pathway and Inhibits Growth in Small Cell Lung Cancer Cells (2008) (4)
Use of the gamma probe to identify multigland disease in primary hyperparathyroidism. (2016) (4)
Chrysin induces growth suppression through apoptosis in neuroblastoma cells (2012) (3)
Inadequate Cytology of Thyroid Nodules. Repeat It or Live With It (2011) (3)
Minimally Invasive Radioguided Parathyroidectomy (2013) (3)
Dysadherin specific drug conjugates for the treatment of thyroid cancers with aggressive phenotypes (2017) (3)
Is Focused Minimally Invasive Parathyroidectomy Appropriate for Patients With Familial Primary Hyperparathyroidism? (2012) (3)
Sestamibi-Negative Patients: To Operate or Image? (2012) (3)
The Natural Flavinoid, Chrysin, in the Treatment of Medullary Thyroid Cancer (2012) (3)
Notch1 signaling regulates wound healing (2010) (3)
Histone Deacetylase Inhibitors Transcriptionally Regulate Notch1 Expression in Neuroendocrine Malignancies (2010) (3)
Azacytidine Induces Growth Arrest and Suppresses Neuroendocrine Markers in Carcinoids (2010) (3)
Thiocoraline Regulates Neuroendocrine Phenotype and Inhibits Proliferation in Carcinoid Tumor Cells (2012) (3)
Technique of thymectomy by anterior-superior cervicomediastinal exenteration. (2002) (2)
Is endocrine surgery research dying? (2010) (2)
Notch 1 signaling inhibits MTC growth OVER EXPRESSION OF THE NOTCH 1 INTRACELLULAR DOMAIN ( NICD ) INHIBITS CELLULAR PROLIFERATION AND ALTERS THE NEUROENDOCRINE PHENOTYPE OF MEDULLARY THYROID CANCER CELLS (2006) (2)
Nonoperative management of primary hyperparathyroidism: the exception rather than the rule (2009) (2)
Thyroid hormone replacement in women of reproductive age: is surgeon knowledge related to operative volume? (2010) (2)
Minimal Benefit to Subsequent Intraoperative Parathyroid Hormone Testing After All Four Glands Have Been Identified (2013) (1)
Parathyroid Hormone Deficiency after Total Thyroidectomy: Incidence and Time to Resolution (2010) (1)
ASSOCIATION FOR ACADEMIC SURGERY Total Thyroidectomy: A Safe and Effective Treatment for Graves' Disease (2011) (1)
Pancreas Cancer Molecular Targets for Therapy (2011) (1)
The Handbook of Endocrine Surgery (2011) (1)
Machine learning is superior to traditional modeling: a parathyroid hormone calculator example (2014) (1)
Velaparib (ABT-888), a Novel Inhibitor of Poly-Adp Ribosyl Polymerase (PARP), Synergizes With 5-Fluorouracil in Pancreatic Carcinoid Cells (2013) (1)
Validation Of A Novel Notch Activating Agent, Chrysin, As A Potential Therapy For Carcinoid Cancer (2011) (1)
Abstract 1014: Thailandepsin A, a new HDAC inhibitor, reduces cellular proliferation and activates the Notch pathway in human carcinoids cancer cells. (2013) (1)
Surgery: Papillary thyroid cancer—how aggressive should surgery be? (2015) (1)
Novel Parathyroid Hormone (1-84) Assay as Basis for Parathyroid Hormone Monitoring in Renal Hyperparathyroidism—Invited Critique (2006) (1)
QS359. ZM336372 Induces Apoptosis and Growth Arrest in Pancreatic Adenocarcinoma Cell Lines (2009) (1)
QS286. Notch 1 Down-Regulation by Gamma-Secretase Inhibition Decreases Ovarian Cancer Cell Growth (2008) (1)
Notch1 Signaling Regulates G1-S and G2-M Phase in Keratinocyte Cell Cycle During Wound Healing (2012) (1)
Doing Away with the Rule of 10 % (2013) (1)
Metastatic Neuroendocrine Hepatic Tumors (2016) (1)
Integrated oral session 3: Fri 2/9 7:30 amCardiothoracic II: Thoracic and Thoracic-vascular/Foreign Society144: Trichostatin a induces morphologic differentiation and inhibits growth in small cell lung cancer cells (2007) (1)
Pre-operative management of patients with Graves' disease. (2008) (1)
RESEARCH REVIEW Pancreatic Endocrine Tumors (2004) (1)
Laryngeal Complications After Thyroidectomy—Invited Critique (2009) (1)
Role of Notch1 in NIKS cellular differentiation (2011) (1)
Does levothyroxine administration impact parathyroid localization? (2015) (1)
Surgical oncology/endocrine IProspective Intervention of a Novel Levothyroxine Dosing Protocol based on Body Mass Index after Thyroidectomy (2014) (1)
Resveratrol inhibits metastatic follicular thyroid cancer cell growth (2009) (1)
143. Focal Adhesion Kinase (FAK) Is A Downstream Effector of the Raf-1 Signal Transduction Pathway in Gastrointestinal Carcinoid Cancer Cells (2008) (1)
PtdIns 3-kinase (2011) (1)
Effective Time Management Strategies for Conducting Laboratory Research (2014) (1)
Recurrent Primary Hyperparathyroidism Occurs More Frequently in Patients with Double Adenomas (2014) (0)
The Role of Achaete-Scute Complex-Like1 in Carcinoids (2012) (0)
Activation of MEK1, a Raf-1 effector, results in morphologic transdifferentiation in pancreatic carcinoid tumor cells (2006) (0)
QS275. AKT and PTEN Expression in Human Carcinoid Tumors (2009) (0)
Ar eSurgica lProgen yMor eLikel yt oPursu ea Surgica lCareer (2008) (0)
The Necessity and Reliability of Intraoperative Parathyroid Hormone (PTH) Testing in Patients with Mild Hyperparathyroidism and PTH Levels in the Normal Range: Reply (2011) (0)
Teriflunomide activates the Notch pathway and leads to carcinoid cancer growth suppression by cell cycle arrest (2009) (0)
Hypertension Reduction after Parathyroidectomy for Primary Hyperparathyroidism (2014) (0)
QS322. Medical Students Whose Family Members are Surgeons are More Likely to Pursue a Surgical Career (2008) (0)
Chapter-11 Intraoperative Parathyroid Hormone Monitoring (2017) (0)
The transabdominal minimally invasive approach to the isolated adrenal mass (2015) (0)
ZM336372, a novel raf-1 activating compound, suppresses cellular growth, induces cell-cycle inhibitors, and reduces hormone production in carcinoid tumor cells (2004) (0)
Modern-Day Presentation of Primary Hyperparathyroidism (2013) (0)
B 11 Hesperitin , a Potential Therapy for Carcinoid Cancer (0)
Population Candidate Gene Association Study (2011) (0)
The Limitations of an IPTH-Based Protocol for the Prevention of Symptomatic Hypocalcemia After Thyroidectomy (2013) (0)
QS127. Follicular Thyroid Cancer Cell Growth Suppression by MG132, a Proteosome Inhibitor (2009) (0)
Antiplatelet and Anticoagulant Medications Significantly Increase the Risk of Postoperative Hematoma: A Review of More than 4,500 Thyroid and Parathyroid Procedures (2014) (0)
In vivo activation of raf-1 inhibits tumor growth and development in a xenograft model of human MTC (2006) (0)
Tautomycetin suppresses carcinoid tumor growth and bioactive hormone production through inactivation of glycogen synthase kinase-3 beta (2008) (0)
Notch1 signaling regulates the neuroendocrine phenotype of medullary thyroid cancer cells (2004) (0)
Abstract 1953: Co-delivery of doxorubicin and siRNA using octreotide-conjugated gold nanorods for targeted neuroendocrine cancer therapy (2012) (0)
QS20. Mediastinal Parathyroid Adenomas: What Is the Best Operative Approach? (2008) (0)
Primary Hyperparathyroidism Throughout the Ages: Disease Presentation, Characteristics and Outcomes (2014) (0)
Principles of Minimally Invasive Parathyroidectomy (2008) (0)
Activation of Mek Alters Morphology and Neuroendocrine Phenotype in Medullary Thyroid Cancer Cell (2016) (0)
Review Article Notch in the development of thyroid C-cells and the treatment of medullary thyroid cancer (2010) (0)
Down-Regulation of Notch1 Expression in Papillary Thyroid Carcinoma Correlates With Advanced Age and Tumor Aggressiveness (2012) (0)
QS131. Curcumin Alters Neuroendocrine Phenotype and Supressess Cell Proliferation in Carcinoid Tumor Cells (2009) (0)
Notch1 Intracellular Domain Regulates Cell Proliferation and Migration in Well-differentiated Thyroid Carcinoma (2013) (0)
167. The Synergistic Effects of Octreotide and RAF-1 Actvation in Carcinoid Cancer Cells (2009) (0)
Hurthie Cell Neoplasms oftheThyroid AreThereFactors Predictive ofMalignancy (1998) (0)
A Family History of Thyroid Cancer Is Associated with More Aggressive Disease (2010) (0)
EDC-1: A New Targeted Drug With Anti-Proliferative Effects on Late Stage Thyroid Cancers (2013) (0)
Sometimes less is more. (2011) (0)
QS129. Sodium Butyrate Inhibits Cellular Proliferation and Reduces Aberrant Hormone Production in Pheochromocytoma (2009) (0)
Outcomes After Endoscopic or Surgical Resection of Non-Appendiceal Colonic Carcinoids (2013) (0)
Does a Multidisciplinary Thyroid Clinic Improve Follow up of Benign and Indeterminate Thyroid Nodules After Fine Needle Aspiration (2014) (0)
Resveratrol Induces Apoptosis and Suppresses Neuroedocrine Markers in Medullary Thryoid Cancer (2010) (0)
ASSOCIATION FOR ACADEMIC SURGERY Expression of the Active Notch1 Decreases MTC Tumor Growth In Vivo (2011) (0)
Increased Efficiency of Endocrine Procedures Performed In An Ambulatory Operating Center (2013) (0)
37. Combination Therapy With Lithium Chloride and Valproic Acid: A Novel Treatment for Gastrointestinal Neuroendocrine Tumors (2008) (0)
The Novel Histone Deacetylase Inhibitor Thailandepsin-A Inhibits Anaplastic Thyroid Cancer Growth via Apoptosis and Cell Cycle Arrest (2014) (0)
Resveratrol regulates the Notch2-mediated neuroendocrine phenotype in human carcinoid cancer cells (2009) (0)
Should Minimally Invasive Follicular Thyroid Cancer Be Treated as a Benign or Malignant Lesion (2014) (0)
Has the availability of minimally invasive techniques lowered the threshold for surgery in elderly patients with hyperparathyroidism (2004) (0)
Síndrome de Cushing subclínico en encidentalomas suprarrenales (2004) (0)
Notch1 Signaling is Critical for Keratinocyte Migration During Wound Healing (2012) (0)
QS264. Efficacy of Fine-Needle Aspiration Biopsy for Detecting Malignancy in Males With Thyroid Nodules (2009) (0)
A Novel HDAC Inhibitor AB3 Reduces Cell Proliferation and Induces the Notch Pathway in Medullary Thyroid Cancer Cells (2014) (0)
101: In vitro and in vivo carcinoid cell growth inhibition by glycogen synthase kinase-3β (2007) (0)
Effects of the Mek inhibitor UO126 on growth of cancer cell lines HepG2, MiaPaca, Panc-1, and HT-29 (2006) (0)
Overexpression of Dysadherin in Thyroid Cancer is Associated with Tumor Aggressive Phenotypes (2014) (0)
Abstract 3085: Overexpression of theNOTCH3intracellular domain alters neuroendocrine phenotype in carcinoid tumor cells (2010) (0)
Consensus Statement (2004) (0)
Parathyroid surgery in children (2020) (0)
PTH Elevation After Curative Parathyroidectomy Delays Symptom Improvement (2014) (0)
W1839 Combination Therapy with Suberoyl Bis-Hydroxamic Acid (SBHA) and Lithium Chloride for Gastrointestinal Carcinoid Tumors (2008) (0)
Regulation of the neuroendocrine phenotype in pancreatic carcinoid tumor cells (2001) (0)
ASSOCIATION FOR ACADEMIC SURGERY ZM336372 Induces Apoptosis Associated with Phosphorylation of GSK-3b in Pancreatic Adenocarcinoma Cell Lines (2010) (0)
Thyroid and Parathyroid Disorders in Children (2020) (0)
NOTCH3 Expression Suppresses Growth and Induces Cell Cycle Arrest in Follicular Thyroid Cancer (2014) (0)
Medullary Thyroid Cancer: Is the Adequacy of Pre-operative Evaluation Influenced By Training Background? (2015) (0)
Extracellular Drug Conjugate (EDC1) Technology for Targeted Neuroendocrine Cancer Therapy (2013) (0)
180. MEK1 Alters Neuroendocrine Phenotype in Carcinoid Cells (2009) (0)
Notch1 Is a Downstream Effector of Raf-1 Signaling in Gastrointestinal Carcinoid Cells (2010) (0)
Immediate and Long Term Outcomes Following Resection of An Aldosterone-Secreting Adrenal Tumor: Management of Hypokalemia and Hypertension (2012) (0)
Identification of Sirpa and Mapk AS Downstream Targets of Notch3 in Medullary Thyroid Carcinoma (2013) (0)
Abstract 2181: Tumor suppressor role of Notch3 in medullary thyroid carcinoma (2011) (0)
Does Previous Head and Neck Irradiation Increase the Chance of Multi-gland Disease in Patients with Hyperparathyroidism? (2011) (0)
Annual Medical Student Research Forum Program and Abstracts Blockinpm Student Blockinresearch Blockinposter Blockinsession (2010) (0)
Persistently elevated serum thyroglobulin levels predict lateral recurrence in patients with papillary thyroid cancer and lateral neck nodal metastases (2012) (0)
Response to “Response to: Tertiary hyperparathyroidism: Is less than a subtotal resection ever appropriate? A study on long-term outcomes” (2010) (0)
P76: Carcinoid tumor cell growth suppression directly relates to levels of Notch1 expression (2007) (0)
Endoscopic transanal resection provides palliation equivalent to transabdominal resection in patients with metastatic rectal adenocarcinoma (2000) (0)
Markedly Elevated Thyroglobulin Levels in the Pre-operative Thyroidectomy Patient Predict Cancer and Metastatic Burden (2013) (0)
A Short-Stay Unit for the Post-Operative Care of Thyroidectomy Patients Increases Discharge Efficiency (2013) (0)
The Synergistic Effects of the Somatostatin Analog Pasireotide (SOM230) and Raf-1 Pathway Activation in Human Carcinoid Cancer Cells (2010) (0)
Thermal Profiles Of Vessel Sealing Devices On Thyroid Parenchyma Using Infrared Thermography (2011) (0)
M1855 Over-Expression of Focal Adhesion Kinase Inhibits Cell Proliferation in Gastrointestinal Neuroendocrine Tumor Cells (2008) (0)
Integrated oral poster session 1: Wed 2/7 5:00 pmOncology IX: Cell signalingP70: Notch1 signaling mediated growth arrest in prostate cancer cells by valproic acid (2007) (0)
Meta-Analysis Preventing Hypocalcemia After Thyroidectomy : A Systematic Review and Role of Postoperative Vitamin D and / or Calcium Routine Supplementation in (2013) (0)
Medullary Thyroid Cancer (2009) (0)
Targeted Delivery of Thailandepsin A using Unimolecular Micelles to Improve Antitumor Effect in Carcinoids (2014) (0)
Clinical Management of Primary Hyperparathyroidism (2011) (0)
M1859 The Effect of ras/raf-1 Pathway Activation On Somatostatin Receptors in Gastrointestinal Carcinoid Tumor Cells (2008) (0)
GSK-3 Inhibition With AR-A014418 and SB415286 Alters the Neuroendocrine Phenotype in Neuroblastoma Cells (2013) (0)
Original Article Is endocrine surgery research dying (2010) (0)
Thiocoraline Reduces Cell Proliferation and Activates the Notch Pathway in Medullary Thyroid Cancer Cells (2013) (0)
Sometimes Less Is More: Comment on “Effect of Incomplete Parathyroidectomy Preserving Entire Parathyroid Glands on Renal Graft Function” (2011) (0)
178. Microrna Profiling in Pheochromocytoma (2009) (0)
Mk2206, an Akt Inhibitor, Attenuates Growth and Neuroendocrine Tumor Markers Expression in Human Gastrointestinal Carcinoid BON Cells (2012) (0)
I sHashimoto' sThyroiditi sa Ris kFacto rfo rPapillar yThyroi dCancer? (2008) (0)
In vitro activity of ABT-888 (A), 5-FU (F), and dacarbazine (D) in neuroendocrine tumors (NET). (2014) (0)
16. The Radioguided Gamma Probe Facilitates Intraoperative Localization of Intrathyroidal Parathyroid Glands During Parathyroidectomy (2009) (0)
38. Akt-1 Inhibition Is Important for Suppression of Neuroendocrine Hormone Secretion in Carcinoid Tumor Cells (2008) (0)
87: Valproic acid activates Notch1 signaling and suppresses the neuroendocrine phenotype in carcinoid cells (2007) (0)
Conservation of the notch1 signaling pathway in gastrointestinal (GI) neuroendocrine (NE) tumor cells (2003) (0)
PL13. Identification and Validation of the Novel Notch1 Activator, Resveratrol, via a Quantitative High-Throughput Assay (2009) (0)
Comprar The Handbook Of Endocrine Surgery | Rebecca S. Sippel | 9789814293198 | World Scientific Publishing (2011) (0)
Hesperetin Activates the Notch1 Signaling Cascade, Induces Cellular Differentiation, and Causes Apoptosis in Anaplastic Thyroid Cancer (2012) (0)
The Epstein‐Barr virus EBNA2 protein induces a subset of NOTCH target genes in thyroid cancer cell lines but fails to suppress proliferation (2017) (0)
86. Unilateral Ovarian Agenesis: A Systematic Review of the Literature and Report of Two Cases (2021) (0)
Rare Ectopic Parathyroid Adenomas in the Neck – Pearls and Pitfalls (2012) (0)
Thailandepsin A, a Novel HDAC Inhibitor, Decreases Tumor Cell Survival and Activates the Notch Pathway in Carcinoid Cancer (2014) (0)
Abstract 3923: Molecular characterization of an animal model for neuroendocrine thyroid cancer (2014) (0)
The Incidence of Concomitant Thyroid Disease and Hyperparathyroidism in Patients Undergoing Thyroidectomy or Parathyroidectomy, and the Role of Routine Pre-operative Calcium and Parathyroid Hormone Testing (2012) (0)
The Synergistic Effect of Pasireotide and a Raf-1 Activating Agent in Carcinoids (2011) (0)
PI3K-Akt signaling in pulmonary carcinoid cells (2008) (0)
2. MG132 Inhibits Neuroendocrine Tumor Markers and Mediates Cell Cycle Arrest via Inhibition of Glycogen Synthase Kinase 3-Beta in Pulmonary Carcinoid Cancer Cells (2009) (0)
Suberoylanilide hydroxamic acid activates Notch1 signaling and induces apoptosis in medullary thyroid cancer cells (2007) (0)
Completion Thyroidectomy is Safe at a High Volume Center (2014) (0)
Abstract 951: Preclinical evaluation of Xanthohumol in carcinoid cancer growth in vitro and in vivo (2012) (0)
Does the presence of an anti-TPO antibody predict clinical hypothyroidism or thyroiditis on pathology? (2015) (0)
Resolution of Thyroglobulin Antibodies after Total Thyroidectomy for Cancer (2014) (0)
Primary Cancer Site (2011) (0)
Regional lymph node metastasis: what does it tell us about adrenocortical carcinoma? (2014) (0)
QS40. Surgical Subspecialty Choice: The Influence of Mentors (2008) (0)
A Newly Synthesized Collection of SAHA Analogs Show High Potency and Notch Induction in Carcinoid Cancer (2014) (0)
Analysis of 405 Parathyroid Glands Resected During Radioguided Parathyroidectomy for Tertiary Hyperparathyroidism (2013) (0)
Thyroid Lymphoma and Other Metastatic Lesions (2012) (0)
Authors' reply: Controversy on papillary thyroid microcarcinoma management (2012) (0)
The ABSITE Review, Second Edition, Steven M. Fiser (Ed.). Lippincott Williams Wilkins, Philadelphia, PA (2007), ISBN-13: 978078-770538, 336 pages, paperback, $59.95 (2008) (0)

This paper list is powered by the following services:

Herbert C. Chen's Academic­Influence.com Rankings

Why Is Herbert C. Chen Influential?

Herbert C. Chen's Published Works

Published Works

Herbert C. Chen's AcademicInfluence.com Rankings